Yalcin Bektas Murat, Karahan Tevfik Fikret, Ozcelik Muhittin, Igde Fusun Artiran
The Faculty of Medicine, Department of Family Medicine, Ondokuz Mayis University, Kurupelit, Samsun, Turkey (Dr Yalcin, Dr Igde)
Faculty of Education, Department of Psychological Counseling and Guidance, Ondokuz Mayis University, Kurupelit, Samsun, Turkey (Dr Karahan)
Diabetes Educ. 2008 Nov-Dec;34(6):1013-24. doi: 10.1177/0145721708327303.
The purpose of the study is to investigate the effect of an emotional intelligence program on the health-related quality of life and well-being of individuals with type 2 diabetes.
The BarOn Emotional Intelligence Scale (EQ-I), WHO Well-Being Questionnaire (WHO-WBQ-22), WHO Quality of Life Measure (WHOQOL-Bref), and the Medical Outcomes Study 36-Item Health Survey (SF-36) were administered to 184 patients with type 2 diabetes who volunteered to participate. Thirty-six patients with the lowest test scores on the WHO-WBQ-22, WHOQOL-Bref, and SF-36 were randomized into study and control groups (18 patients each). A 12-week emotional intelligence program was administered to the study group. At the end of the program, scales were readministered to both groups and again at 3 and 6 months.
There were no differences between the quality of life, well-being, and emotional intelligence levels of the study and control groups before the commencement of the program (P > .05). At the conclusion of the program, quality of life, well-being, and emotional intelligence levels of study group patients increased in comparison with those in the control group (P < .001). The positive effect of the program on study groups' quality of life, wellbeing, and emotional intelligence persisted at the 3- and 6-month follow-up.
The emotional intelligence program may have positive effects on quality of life and well-being of individuals with type 2 diabetes.
本研究旨在探讨一项情商计划对2型糖尿病患者健康相关生活质量和幸福感的影响。
对184名自愿参与的2型糖尿病患者进行了巴昂情商量表（EQ-I）、世界卫生组织幸福感问卷（WHO-WBQ-22）、世界卫生组织生活质量量表（WHOQOL-Bref）以及医学结局研究36项健康调查（SF-36）的测试。将在WHO-WBQ-22、WHOQOL-Bref和SF-36测试中得分最低的36名患者随机分为研究组和对照组（每组18名患者）。对研究组实施了为期12周的情商计划。在计划结束时，对两组再次进行量表测试，并在3个月和6个月后再次测试。
在计划开始前，研究组和对照组的生活质量、幸福感和情商水平没有差异（P > 0.05）。在计划结束时，研究组患者的生活质量、幸福感和情商水平与对照组相比有所提高（P < 0.001）。该计划对研究组生活质量、幸福感和情商的积极影响在3个月和6个月的随访中持续存在。
情商计划可能对2型糖尿病患者的生活质量和幸福感产生积极影响。
